Aflac (NYSE:AFL) Price Target Raised to $90.00

Aflac (NYSE:AFL) had its target price raised by investment analysts at JPMorgan Chase & Co. from $85.00 to $90.00 in a report released on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price objective would indicate a potential downside of 21.92% from the stock’s previous close.

A number of other research analysts also recently issued reports on the company. Truist Financial boosted their price objective on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Jefferies Financial Group reduced their target price on Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a report on Friday, June 28th. Piper Sandler upped their target price on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a report on Wednesday. Wells Fargo & Company upped their price objective on Aflac from $81.00 to $90.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Finally, Evercore ISI increased their target price on Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research report on Thursday, September 26th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, Aflac has an average rating of “Hold” and a consensus price target of $95.43.

Aflac Trading Up 1.5 %

Shares of AFL opened at $115.27 on Thursday. Aflac has a 52-week low of $75.07 and a 52-week high of $115.50. The business’s fifty day moving average is $106.42 and its 200-day moving average is $93.88. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The firm has a market cap of $65.50 billion, a price-to-earnings ratio of 12.72, a PEG ratio of 2.60 and a beta of 0.95.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. Aflac’s quarterly revenue was down .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS. Equities analysts anticipate that Aflac will post 6.75 EPS for the current fiscal year.

Insider Activity

In related news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now directly owns 18,158 shares of the company’s stock, valued at $1,796,552.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.90% of the company’s stock.

Institutional Trading of Aflac

Several large investors have recently bought and sold shares of the company. J. W. Coons Advisors LLC boosted its position in shares of Aflac by 3.1% in the 4th quarter. J. W. Coons Advisors LLC now owns 14,836 shares of the financial services provider’s stock worth $1,224,000 after purchasing an additional 440 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Aflac by 2.3% in the 4th quarter. The Manufacturers Life Insurance Company now owns 386,538 shares of the financial services provider’s stock worth $31,889,000 after purchasing an additional 8,821 shares in the last quarter. CIBC Private Wealth Group LLC boosted its position in shares of Aflac by 8.1% in the 4th quarter. CIBC Private Wealth Group LLC now owns 37,733 shares of the financial services provider’s stock worth $3,113,000 after purchasing an additional 2,831 shares in the last quarter. Lake Street Advisors Group LLC bought a new stake in shares of Aflac in the 4th quarter worth approximately $325,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of Aflac by 306.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 75,739 shares of the financial services provider’s stock worth $6,248,000 after purchasing an additional 57,104 shares in the last quarter. 67.44% of the stock is owned by institutional investors.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.